-
Signature
-
/s/ Kathleen Scott, Attorney-in-Fact
-
Issuer symbol
-
SPRY
-
Transactions as of
-
18 Jun 2025
-
Net transactions value
-
-$217,500
-
Form type
-
4
-
Filing time
-
20 Jun 2025, 18:38:45 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Karas Eric |
Chief Commercial Officer |
C/O ARS PHARMACEUTICALS, INC., 11682 EL CAMINO REAL, SUITE 120, SAN DIEGO |
/s/ Kathleen Scott, Attorney-in-Fact |
20 Jun 2025 |
0001951287 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
SPRY |
Common Stock |
Options Exercise |
$22,500 |
+15,000 |
+195% |
$1.50 |
22,696 |
18 Jun 2025 |
Direct |
|
| transaction |
SPRY |
Common Stock |
Sale |
$240,000 |
-15,000 |
-66% |
$16.00 |
7,696 |
18 Jun 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
SPRY |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-15,000 |
-2.6% |
$0.000000 |
559,588 |
18 Jun 2025 |
Common Stock |
15,000 |
$1.50 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: